IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DLD Asset Management, LP

Q2 2018 Holdings

Filed 2018-08-14 | 115 holdings | $1.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Intra Cellular Therapies Inc(ITCIEUR)CallCOM46116X101$20.5K1,159,3001.3%
Microchip Technology IncNOTE 1.625% 2/1595017AD6$22.0K$12,500,0001.4%
Convergys CorpSDCV 5.750% 9/1212485AE6$25.0K$11,000,0001.5%
Medicines CoNOTE 2.500% 1/1584688AE5$27.5K$22,500,0001.7%
Herbalife LTDNOTE 2.000% 8/142703MAB9$27.8K$21,500,0001.7%
Tesaro IncNOTE 3.000%10/0881569AA5$29.8K$20,000,0001.8%
Insmed IncNOTE 1.750% 1/1457669AA7$34.5K$37,500,0002.1%
American Express Co(AXP)PutCOM025816109$39.2K400,0002.4%
Immunomedics Inc(IMMU)CallCOM452907108$57.1K2,411,6003.5%
Vector Group LTDFRNT 1/192240MAY4$58.7K$43,500,0003.6%
Immunomedics Inc(IMMU)PutCOM452907108$63.5K2,682,1003.9%
Caesars Entmt CorpNOTE 5.000%10/0127686AA1$90.2K$53,000,0005.5%
Yahoo IncNOTE 12/0984332AF3$109.5K$80,000,0006.7%
Molina Healthcare IncNOTE 1.125% 1/160855RAC4$123.5K$51,000,0007.6%
Akebia Therapeutics Inc(AKBA)COM00972D105$299.0K30,00018.4%
PreviousPage 3 of 3